Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin I and T

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 1, 2008, Pages 72-76

  Lippi, Giuseppe ^a,b   Tessitore, Nicola ^a   Montagnana, Martina ^a   Salvagno, Gian Luca ^a   Lupo, Antonio ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIALYSIS MEMBRANE; DISEASE MARKER; FEMALE; HEART MUSCLE INJURY; HEMOCONCENTRATION; HEMODIALYSIS; HUMAN; MALE; MEASUREMENT; OUTCOME ASSESSMENT; PREDICTION; RISK ASSESSMENT; SAMPLING; STATISTICAL ANALYSIS; ULTRAFILTRATION;

BIOLOGICAL MARKERS; FEMALE; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; TROPONIN I; TROPONIN T;

EID: 38049071133     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Cameron SJ, Green GB. Cardiac biomarkers in renal disease: the fog is slowly lifting. Clin Chem. 2004;50:2233-2235.
2. Panteghini M. The new definition of myocardial infarction and the impact of troponin determination on clinical practice. Int J Cardiol. 2006;106:298-306.
3. Abbas NA, John RI, Webb MC, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem. 2005;51:2059-2066.
4. Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation. 2004;109:23-25.
5. Fahie-Wilson MN, Carmichael DJ, Delaney MP, Stevens PE, Hall EM, Lamb EJ. Cardiac troponin T circulates in the free, intact form in patients with kidney failure. Clin Chem. 2006;52:414-420.
6. Fahie-Wilson MN, Hall EM, Lamb EJ. The authors of the article cited above respond. Clin Chem. 2006;52:2307-2309.
7. Freda BJ, Tang WH, Van Lente F, Peacock WF, Francis GS. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol. 2002; 40:2065-2071.
8. Hojs R. Cardiac troponin T in patients with kidney disease. Ther Apher Dial. 2005;9:205-207.
9. Apple FS, Jaffe AS, Herzog CA. Letter regarding article by Khan et al, "Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis." Circulation. 2006;113:e775.
10. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem. 2004;50:2279-2285.
11. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation. 2005;112:3088-3096.
12. Giannitsis E, Katus HA. Troponin T release in hemodialysis patients. Circulation. 2004;110:e25-e26.
13. Deleaval P, Descombes E, Magnin JL, Martin PY, Fellay G. Differences in cardiac troponin I and T levels measured in asymptomatic hemodialysis patients with last generation immunoassays. Nephrol Ther. 2006;2:75-81.
14. Tarakcioglu M, Erbagci A, Cekmen M, et al. Acute effect of haemodialysis on serum markers of myocardial damage. Int J Clin Pract. 2002;56:328-332.
15. Conway B, McLaughlin M, Sharpe P, Harty J. Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrol Dial Transplant. 2005;20:2759-2764.
16. Urso S, Garozzo M, Milone F, Battaglia G. Cardiovascular risk markers in hemodialysis patients. Int J Artif Organs. 2004;27:1083-1090.
17. Wayand D, Baum H, Schatzle G, Scharf J, Neumeier D. Cardiac troponin T and I in end-stage renal failure. Clin Chem. 2000;46:1345-1350.
18. Apple FS, Pearce LA, Doyle PJ, Otto AP, Murakami MM. Cardiac troponin risk stratification based on 99th percentile reference cutoffs in patients with ischemic symptoms suggestive of acute coronary syndrome: influence of estimated glomerular filtration rates. Am J Clin Pathol. 2007;127:598-603.
19. Kupchak P, Wu AH, Ghani F, Newby LK, Ohman EM, Christenson RH. Influence of imprecision on ROC curve analysis for cardiac markers. Clin Chem. 2006;52:752-753.
20. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume kt/V: an analysis of error. J Am Soc Nephrol. 1993;4:1205-1213.
21. Lauer MS. Cardiac troponins and renal failure: the evolution of a clinical test. Circulation. 2005;112:3036-3037.
22. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation. 2002;106:2941-2945.
23. Abaci A, Ekici E, Oguzhan A, Tokgoz B, Utas C. Cardiac troponins T and I in patients with end-stage renal disease: the relation with left ventricular mass and their prognostic value. Clin Cardiol. 2004;27:704-709.
24. Dolci A, Dominici R, Luraschi P, Panteghini M. 10% CV concentration for the fourth generation Roche cardiac troponin T assay derived from Internal Quality Control data. Clin Chem Lab Med. 2006;44:1495-1496.
25. Wu AH, Feng YJ. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J. 1998; 19:N25-N29.
26. Ooi DS, House AA. Cardiac troponin T in hemodialyzed patients. Clin Chem. 1998;44:1410-1416.
27. Porter GA, Norton T, Bennett WM. Long term follow up of the utility of troponin T to assess cardiac risk in stable chronic hemodialysis patients. Clin Lab. 2000;46:469-476.
28. Mockel M, Schindler R, Knorr L, et al. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: a 9-month outcome analysis. Nephrol Dial Transplant. 1999;14:1489-1495.
29. Roppolo LP, Fitzgerald R, Dillow J, Ziegler T, Rice M, Maisel A. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: a pilot study. J Am Coll Cardiol. 1999;34:448-454.
30. Lowbeer C, Stenvinkel P, Pecoits-Filho R, et al. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med. 2003;253:153-160.
31. deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003;290:353-359.
32. Fernandez-Reyes MJ, Mon C, Heras M, et al. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis. J Nephrol. 2004;17:721-727.
33. Iliou MC, Fumeron C, Benoit MO, et al. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Am J Kidney Dis. 2003;42:513-523.
34. Beciani M, Tedesco A, Violante A, et al. Cardiac troponin I (2nd generation assay) in chronic haemodialysis patients: prevalence and prognostic value. Nephrol Dial Transplant. 2003;18:942-946.
35. Ie EH, Klootwijk PJ, Weimar W, Zietse R. Significance of acute versus chronic troponin T elevation in dialysis patients. Nephron Clin Pract. 2004;98:c87-c92.
36. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM. 2006;8:27-31.
37. Fehr T, Knoflach A, Ammann P, Pei P, Binswanger U. Differential use of cardiac troponin T versus I in hemodialysis patients. Clin Nephrol. 2003;59:35-39.